11/19
06:50 am
solv
Solventum to Participate in the Piper Sandler Healthcare Conference
Low
Report
Solventum to Participate in the Piper Sandler Healthcare Conference
11/14
09:00 am
solv
Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment
Low
Report
Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment
11/11
08:09 am
solv
Solventum Co. (NYSE: SOLV) had its price target raised by analysts at Morgan Stanley from $60.00 to $73.00. They now have an "equal weight" rating on the stock.
Low
Report
Solventum Co. (NYSE: SOLV) had its price target raised by analysts at Morgan Stanley from $60.00 to $73.00. They now have an "equal weight" rating on the stock.
11/7
04:05 pm
solv
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance
Medium
Report
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance
10/15
06:50 am
solv
Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
Low
Report
Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
10/14
07:00 am
solv
Solventum Announces Commitment to 100% Renewable Electricity by 2030
Low
Report
Solventum Announces Commitment to 100% Renewable Electricity by 2030
10/10
09:00 am
solv
Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer
Low
Report
Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer
10/8
08:39 am
solv
Solventum Co. (NYSE: SOLV) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $82.00 price target on the stock.
Low
Report
Solventum Co. (NYSE: SOLV) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $82.00 price target on the stock.
10/7
08:17 am
solv
Solventum Co. (NYSE: SOLV) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $71.00 price target on the stock.
Low
Report
Solventum Co. (NYSE: SOLV) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $71.00 price target on the stock.
9/26
08:13 am
solv
Solventum Co. (NYSE: SOLV) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Low
Report
Solventum Co. (NYSE: SOLV) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
9/10
06:45 am
solv
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy
Low
Report
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy
9/5
08:06 am
solv
Solventum Co. (NYSE: SOLV) is now covered by analysts at BTIG Research. They set a "neutral" rating on the stock.
Low
Report
Solventum Co. (NYSE: SOLV) is now covered by analysts at BTIG Research. They set a "neutral" rating on the stock.
8/28
06:50 am
solv
Solventum to Participate in Upcoming Investor Conferences
Low
Report
Solventum to Participate in Upcoming Investor Conferences